These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11159536)

  • 1. Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12).
    Kuno Y; Abe A; Emi N; Iida M; Yokozawa T; Towatari M; Tanimoto M; Saito H
    Blood; 2001 Feb; 97(4):1050-5. PubMed ID: 11159536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TEL-Syk fusion constitutively activates PI3-K/Akt, MAPK and JAK2-independent STAT5 signal pathways.
    Kanie T; Abe A; Matsuda T; Kuno Y; Towatari M; Yamamoto T; Saito H; Emi N; Naoe T
    Leukemia; 2004 Mar; 18(3):548-55. PubMed ID: 14749700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARG tyrosine kinase activity is inhibited by STI571.
    Okuda K; Weisberg E; Gilliland DG; Griffin JD
    Blood; 2001 Apr; 97(8):2440-8. PubMed ID: 11290609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia.
    Peeters P; Raynaud SD; Cools J; Wlodarska I; Grosgeorge J; Philip P; Monpoux F; Van Rompaey L; Baens M; Van den Berghe H; Marynen P
    Blood; 1997 Oct; 90(7):2535-40. PubMed ID: 9326218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TEL-JAK2 mediates constitutive activation of the phosphatidylinositol 3'-kinase/protein kinase B signaling pathway.
    Nguyen MH; Ho JM; Beattie BK; Barber DL
    J Biol Chem; 2001 Aug; 276(35):32704-13. PubMed ID: 11435425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells.
    Lacronique V; Boureux A; Monni R; Dumon S; Mauchauffé M; Mayeux P; Gouilleux F; Berger R; Gisselbrecht S; Ghysdael J; Bernard OA
    Blood; 2000 Mar; 95(6):2076-83. PubMed ID: 10706877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premature terminal differentiation protects from deregulated lymphocyte activation by ITK-Syk.
    Bach MP; Hug E; Werner M; Holch J; Sprissler C; Pechloff K; Zirlik K; Zeiser R; Dierks C; Ruland J; Jumaa H
    J Immunol; 2014 Feb; 192(3):1024-33. PubMed ID: 24376268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia.
    Golub TR; Goga A; Barker GF; Afar DE; McLaughlin J; Bohlander SK; Rowley JD; Witte ON; Gilliland DG
    Mol Cell Biol; 1996 Aug; 16(8):4107-16. PubMed ID: 8754809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway.
    Bai RY; Ouyang T; Miething C; Morris SW; Peschel C; Duyster J
    Blood; 2000 Dec; 96(13):4319-27. PubMed ID: 11110708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zeta-associated protein of 70 kDa (ZAP-70), but not Syk, tyrosine kinase can mediate apoptosis of T cells through the Fas/Fas ligand, caspase-8 and caspase-3 pathways.
    Zhong L; Wu CH; Lee WH; Liu CP
    J Immunol; 2004 Feb; 172(3):1472-82. PubMed ID: 14734724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of STAT5 blocks TEL-SYK-induced APMF-type leukemia with myelofibrosis and myelodysplasia in mice.
    Sprissler C; Belenki D; Maurer H; Aumann K; Pfeifer D; Klein C; Müller TA; Kissel S; Hülsdünker J; Alexandrovski J; Brummer T; Jumaa H; Duyster J; Dierks C
    Blood Cancer J; 2014 Aug; 4(8):e240. PubMed ID: 25148222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of phagocytosis by a protein tyrosine kinase.
    Indik ZK; Park JG; Pan XQ; Schreiber AD
    Blood; 1995 Mar; 85(5):1175-80. PubMed ID: 7858249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusion of the ets transcription factor TEL to Jak2 results in constitutive Jak-Stat signaling.
    Ho JM; Beattie BK; Squire JA; Frank DA; Barber DL
    Blood; 1999 Jun; 93(12):4354-64. PubMed ID: 10361134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An atypical myelodysplastic syndrome with t(9;12)(q22;p12) and TEL gene rearrangement.
    Kuno Y; Abe A; Emi N; Iida M; Yamamori T; Tanimoto M; Saito H
    Br J Haematol; 1999 Aug; 106(2):570-1. PubMed ID: 10460625
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome.
    Odero MD; Vizmanos JL; Román JP; Lahortiga I; Panizo C; Calasanz MJ; Zeleznik-Le NJ; Rowley JD; Novo FJ
    Genes Chromosomes Cancer; 2002 Sep; 35(1):11-9. PubMed ID: 12203785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33).
    Guasch G; Mack GJ; Popovici C; Dastugue N; Birnbaum D; Rattner JB; Pébusque MJ
    Blood; 2000 Mar; 95(5):1788-96. PubMed ID: 10688839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IL-15R alpha chain signals through association with Syk in human B cells.
    Bulanova E; Budagian V; Pohl T; Krause H; Dürkop H; Paus R; Bulfone-Paus S
    J Immunol; 2001 Dec; 167(11):6292-302. PubMed ID: 11714793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning of human Syk. A B cell protein-tyrosine kinase associated with the surface immunoglobulin M-B cell receptor complex.
    Law CL; Sidorenko SP; Chandran KA; Draves KE; Chan AC; Weiss A; Edelhoff S; Disteche CM; Clark EA
    J Biol Chem; 1994 Apr; 269(16):12310-9. PubMed ID: 8163536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatidylinositol-3-kinase-dependent phosphorylation of SLP-76 by the lymphoma-associated ITK-SYK fusion-protein.
    Hussain A; Faryal R; Nore BF; Mohamed AJ; Smith CI
    Biochem Biophys Res Commun; 2009 Dec; 390(3):892-6. PubMed ID: 19850008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma.
    Pechloff K; Holch J; Ferch U; Schweneker M; Brunner K; Kremer M; Sparwasser T; Quintanilla-Martinez L; Zimber-Strobl U; Streubel B; Gewies A; Peschel C; Ruland J
    J Exp Med; 2010 May; 207(5):1031-44. PubMed ID: 20439541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.